Cynomolgus Monkey Treated Subcellular Fractions

XenoTech provides hepatic microsomes from Cynomolgus monkeys treated with prototypical inducers to serve as positive controls for ex vivo enzyme induction studies.

These products are pooled from multiple animals to ensure good representation of the inducer and to provide sufficient product availability.

The following lot-specific product information is included with each order of microsomes:

    •    Specific content of cytochrome P450
    •    Specific content of cytochrome b5
    •    NADPH-cytochrome c reductase activity
    •    Activity of the inducible CYP enzyme
    •    Dosing regimen
    •    Animal husbandry conditions

Induction of specific cytochrome P450 enzymes are obtained through the treatment of mokeys with the following prototypical inducers.

    •    Saline (control)
    •    Phenobarbital
    •    β-Naphthoflavone
    •    Pyrazole
    •    Rifampin
    •    Omeprazole

Packaging


0.5mL at 10mg/mL

Products

Product #NameGenderAmountInduced CYP Control
P2073Saline-treated liver microsomesMale0.5mL @ 10mg/mLno induction
P2078Phenobarbital-treated liver microsomesMale0.5mL @ 10/mg/mLinduced CYP2A and CYP2B
P2083BNF-treated liver microsomesMale0.5mL @ 10mg/mLinduced CYP1A
P2085Pyrazole-treated liver microsomesMale0.5mL @ 10mg/mLinduced CYP2E
P2095Rifampin-treated liver microsomesMale0.5mL @ 10mg/mLinduced CYP3A
P2096Omeprazole-treated liver microsomesMale0.5mL @ 10mg/mLinduced CYP1A
P2573Saline-treated liver microsomesFemale0.5mL @ 10mg/mLno induction
P2578Phenobarbital-treated liver microsomesFemale0.5mL @ 10mg/mLinduced CYP2A and CYP2B
P2583BNF-treated liver microsomesFemale0.5mL @ 10mg/mLinduced CYP1A
P2585Pyrazole-treated liver microsomesFemale0.5mL @ 10mg/mLinduced CYP2E
P2595Rifampin-treated liver microsomesFemale0.5mL @ 10mg/mLinduced CYP3A
P2596Omeprazole-treated liver microsomesFemale0.5mL @ 10mg/mLinduced CYP1A